Generating comparative evidence on new drugs and devices before approvalHuseyin Naci, Andrea Cipriani, Maximilian Salcher‐Konrad et al.|The Lancet|2020Cited by 80
WHY PATIENTS SHOULD BE INVOLVED IN HEALTH TECHNOLOGY ASSESSMENTJanet Wale, Lloyd Sansom, Sarah Garner et al.|International Journal of Technology Assessment in Health Care|2017Cited by 56
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized micePhilip Arandjelovic, Marc Pellegrini, Youry Kim et al.|Cell Reports Medicine|2023Cited by 40